Siemens Healthcare Diagnostics Inc
9
0
1
5
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 75/100
22.2%
2 terminated/withdrawn out of 9 trials
71.4%
-15.1% vs industry average
0%
0 trials in Phase 3/4
20%
1 of 5 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (9)
Detection and Significance of Heart Injury in ST Elevation Myocardial Infarction.
Role: collaborator
Cardiac CT Angiography in Patients With Acute Ischemic Stroke
Role: collaborator
Comparison of Fingerstick Versus Venous Sample for Troponin I.
Role: collaborator
Unifying Advanced Treatment With Advanced Imaging
Role: collaborator
Machine leArning Based CT angiograpHy derIved FFR: a Multi-ceNtEr, Registry
Role: collaborator
Impact of C-arm CT in Patients With HCC Undergoing TACE: Optimal Imaging Guidance
Role: collaborator
Multi-center Evaluation of the VERSANT® CT/GC DNA 1.0 Assay (kPCR)in Detecting C. Trachomatis and N. Gonorrhoeae
Role: lead
Serial BNP Testing for Heart Failure Management
Role: lead
Computed Tomography Dose Reduction Using Sequential or Fast Pitch Sprial Technique
Role: collaborator
All 9 trials loaded